Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia
Clinical trial NCT05254990 · TERMINATED
Trial details
- NCT number
- NCT05254990
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-27
- Primary completion
- 2024-07-29
- Enrollment
- 414
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.